Oncology
News
Q&A: Drug costs and value in cancer
Dr. Richard L. Schilsky, chief medical officer at ASCO, tackles the issue of how to determine the value of cancer drugs.
Conference Coverage
PACIFIC: Patterns of lung cancer progression suggest role for local ablative therapy
Approximately two-thirds of patients with distant progression had one or two new lesions.
News
Many institutions exceed recommended radiation doses during lung cancer screening
Allowing any radiologist, rather than a lead radiologist, to establish CT protocols is associated with high likelihood of exceeding ACR dose...
News
CAR T-cell therapy found safe, effective for HIV-associated lymphoma
Two HIV-positive patients with chemotherapy-refractory, high-grade B-cell lymphoma achieved complete remission with anti-CD19 CAR T-cell therapy,...
FDA/CDC
FDA issues warning for CDK 4/6 inhibitors
In a review of trials and postmarket safety databases, the FDA found there were reports of serious cases of pneumonitis, including fatalities,...
Article
Medical Cannabis: A guide to the clinical and legal landscapes
If your patient expresses interest in medical marijuana, you’ll find evidence on maximizing benefit while minimizing risk. But be cautious: Data...
News
USPSTF recommends preventive breast cancer medications only for women at risk
The USPSTF finds minimal value in medications to help prevent breast cancer for women not at increased risk
Conference Coverage
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
FDA/CDC
Calquence earns breakthrough designation for CLL monotherapy
The Bruton tyrosine kinase inhibitor is already approved for the treatment of adults with mantle cell lymphoma who have received at least one...
Opinion
Ovarian cancer and perineal talc exposure: An epidemiologic dilemma
Recall bias and lack of an established biologic mechanism are a few reasons perineal talc exposure isn’t considered a definitive cause of ovarian...